article thumbnail

New therapeutic target for cardiac arrhythmias emerges

Science Daily - Heart Disease

Researchers identified a lipid that is involved in regulating cardiac ion channels, providing insights into possible mechanisms of cardiac arrhythmias in heart failure and a potential pathway for future therapeutic development.

article thumbnail

Arrhythmias in Pregnancy

American College of Cardiology

However, arrhythmias requiring monitoring or treatment throughout the antepartum and peripartum periods are less frequent. Palpitations during pregnancy are not an uncommon finding.

article thumbnail

Gene-related metabolic dysfunction may be driving heart arrhythmia

Science Daily - Heart Disease

Patients with a common heart arrhythmia called Atrial Fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.

article thumbnail

AHA's statement on COVID-19-associated arrhythmias: 8 takeaways

Becker's Hospital Review - Cardiology

The American Heart Association has released a scientific statement providing guidance on the management of patients with COVID-19-related cardiac arrhythmias and autonomic dysfunction. The statement was published Oct. 14 in Circulation.

article thumbnail

Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association

Circulation

Cardiac arrhythmias are commonly noted in patients during infections with and recovery from COVID-19. Debate continues on the impact of incident and exacerbated arrhythmias on the acute and chronic (recovery) phase of the illness. Circulation, Ahead of Print. Various pathophysiological mechanisms have been proposed.

article thumbnail

Arrhythmias and Autonomic Dysfunction With COVID-19: Key Points

American College of Cardiology

The following are key points to remember from an American Heart Association scientific statement on arrhythmias and autonomic dysfunction associated with coronavirus disease 2019 (COVID-19).

article thumbnail

Dexmedetomidine vs. propofol on arrhythmia in cardiac surgery: a meta-analysis of randomized controlled trials

Frontiers in Cardiovascular Medicine

The primary outcome was ventricular arrhythmias, the secondary outcomes were bradycardia and atrial fibrillation (AF).ResultsOur Perioperative or postoperative use of DEX reduced the incidence of in-hospital ventricular arrhythmias [Odds Ratio (OR) 0.14, 95% Confidence Interval (CI) 0.03–0.66], 8.17) compared with propofol.